ClinicalTrials.gg
CompletedNCT06738121UHRUpdated Aug 22, 2025

Cosmetic Outcomes of Umbilical Hernia Incisions

An interventional study of Infra-umbilical incision and Transumbilical incision in Umbilical Hernia, sponsored by Children's Mercy Hospital Kansas City. Completed at 1 site in United States. Open to participants aged Up to 9 Years. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Children's Mercy Hospital Kansas City · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
Up to 9 Years
Sex
All
01

Study summary

This will be a single institution, prospective, randomized controlled trial. Patients presenting as an outpatient for repair of umbilical hernias who meet our inclusion criteria, whose parents provide permission to participate in the study, will receive the umbilical hernia repair that they are randomized to. The appropriate data will be collected on day of surgery, and patients will be followed with a delayed parental submission of incisional photograph.

02

Conditions studied

  • Umbilical Hernia

Browse trials for

Keywords

  • Umbilical Hernia
03

In context

Hernia, Umbilical

67 studies on the registry are indexed under Hernia, Umbilical; 13 are open to participants now.

This study's enrollment of 2 is below the median of 66 across 40 interventional studies indexed under Hernia, Umbilical.

Browse Hernia, Umbilical studies →

Lead sponsor

Children's Mercy Hospital Kansas City is the lead sponsor of 210 studies on the registry; 20 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 14 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient presenting with umbilical hernia that is \<1.5cm in size based on physical exam for outpatient repair
  • Treated at CMH Adele Hall or CMHK from 09/11/24 - 09/11/25
  • Subjects \<10 years of age

Exclusion criteria

Exclusion Criteria:

  • Umbilical hernia > 1.5 cm in size
  • Patients with prior umbilical surgery
  • Subjects ≥10 years of age
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2 participants (actual)

Study arms

  • Active comparator
    Traditional Infra-umbilical incision

    Patients randomized to this arm with have the traditional curvilinear infra-umbilical incision

    Procedure: Infra-umbilical incision

  • Active comparator
    Vertical Trans-umbilical Incision

    Patients in this arm will have the cranio-caudal vertical incision right through the umbilicus for the repair of the umbilical hernia

    Procedure: Transumbilical incision

Interventions

  • ProcedureInfra-umbilical incision

    Traditional curvilinear infra-umbilical incision is used to repair the umbilical hernia

  • ProcedureTransumbilical incision

    The incision for the repair of the umbilical hernia will be carried through the umbilicus itself.

06

What researchers measure

Primary outcomes

  1. Cosmetic Outcome

    Cosmetic appearance of incision will be measured using the Pediatric Scar Assessment Questionnaire (PSAQ) filled out by patients and a modified version filled out by an independent assessor .

    Time frame: 4 - 6 weeks and 2 years post operation

Secondary outcomes

  1. Operative times

    This will evaluate operative time for each procedure in minutes

    Time frame: Up to 2 years

  2. Surgical site infections

    Assess the rate of surgical site infections in each arm of the study

    Time frame: 30 days

  3. Wound complications

    Evaluate wound complication including wound breakdown and wound dehiscence

    Time frame: 30 days

  4. Recurrence

    Recurrence of the umbilical hernia will be calculated as a rate in each arm

    Time frame: 2 years

07

Study locations

1 site
  • Children's Mercy Hospital and Clinics
    Kansas City, Missouri 64118, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Apr 2025, 1 month.

Of 19 interventional studies with no phase under Hernia, Umbilical, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 47. This study's 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2024
First posted
Dec 17, 2024
StartActual
Mar 20, 2025
Primary completionActual
Apr 23, 2025
CompletionActual
Apr 23, 2025
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06738121
Responsible party
Tolulope Oyetunji (Principal Investigator, Children's Mercy Hospital Kansas City) — Principal investigator
First posted
Dec 17, 2024
Start date
Mar 20, 2025
Primary completion
Apr 23, 2025
Completion
Apr 23, 2025
Last update
Aug 22, 2025

Study contacts

Tolulope A Oyetunji, MD, MPH, MBA
principal investigator · Division Chief, Pediatric General Surgery

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion